ARHGAP29 and gastric cancer: Although the results should be taken with care, one study showed the association of hepatitis with gastric cancer [40], and the link between the two might involve the Rho GTPase activator ARHGAP29, which has been previously associated with gastric cancer [41], and associated with hepatitis in this study.